Denying Obvious GLP-1 Use
Kali Uchis, on September 12, 2025, denying GLP-1 (ex: Ozempic, Wegovy, Mounjaro, etc.) use for rapid weight loss.
Yet the dramatic change in just under two months feels disingenuous, and the post ends up being performative
rather than honest.
By publicly dismissing the obvious while demanding sympathy for her personal struggles, she blurs the line between vulnerability and
manipulation. It’s a toxic cycle: presenting an impossible-to-ignore transformation, denying the methods behind it, and expecting
unquestioned support.
This kind of messaging not only misleads fans but also reinforces unhealthy beauty standards, showing how even
personal grief can be weaponized to excuse or distract from deception.